Citadel Advisors
MLTX icon

Citadel Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Citadel Advisors’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Sell
664,000
-828,800
-56% -$13.7M ﹤0.01% 2948
2025
Q4 		$19.7M Buy
1,492,800
+1,189,600
+392% +$14M ﹤0.01% 2364
2025
Q3 		$2.17M Buy
303,200
+276,600
+1,040% +$14.4M ﹤0.01% 5914
2025
Q2 		$1.26M Buy
26,600
+17,500
+192% +$713K ﹤0.01% 6602
2025
Q1 		$356K Sell
9,100
-2,400
-21% -$103K ﹤0.01% 9219
2024
Q4 		$623K Sell
11,500
-1,700
-13% -$86.8K ﹤0.01% 8067
2024
Q3 		$666K Sell
13,200
-4,100
-24% -$192K ﹤0.01% 7659
2024
Q2 		$761K Sell
17,300
-12,900
-43% -$546K ﹤0.01% 7159
2024
Q1 		$1.52M Buy
30,200
+4,600
+18% +$250K ﹤0.01% 6062
2023
Q4 		$1.55M Buy
25,600
+4,000
+19% +$206K ﹤0.01% 5832
2023
Q3 		$1.23M Buy
+21,600
New +$1.19M ﹤0.01% 6146

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return